You just read:

Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea

News provided by

Jazz Pharmaceuticals plc

Dec 21, 2017, 07:30 EST